Brain Metastases News and Research

RSS
Promising new approaches in the fight against brain metastasis

Promising new approaches in the fight against brain metastasis

Up to 80% of metastatic colorectal cancers spread to far areas before diagnoses

Up to 80% of metastatic colorectal cancers spread to far areas before diagnoses

Elderly survivors of breast, lung, and skin cancers face risk of brain metastasis later in life

Elderly survivors of breast, lung, and skin cancers face risk of brain metastasis later in life

New study highlights need for equity in access to radiation therapy care in rural areas

New study highlights need for equity in access to radiation therapy care in rural areas

Prophylactic cranial irradiation used as standard approach for patients with NSCLC

Prophylactic cranial irradiation used as standard approach for patients with NSCLC

Estrogen can affect surrounding brain cells to promote triple-negative breast cancer metastasis

Estrogen can affect surrounding brain cells to promote triple-negative breast cancer metastasis

Why melanoma tumors in the brain may be worse?

Why melanoma tumors in the brain may be worse?

MGH-led research team reveals how solid stress impacts tissue surrounding brain tumors

MGH-led research team reveals how solid stress impacts tissue surrounding brain tumors

Patients with stage IV disease now living a median 6.8 years after ALK+ NSCLC diagnosis

Patients with stage IV disease now living a median 6.8 years after ALK+ NSCLC diagnosis

Using molecular targeting approach to kill melanoma cells

Using molecular targeting approach to kill melanoma cells

NIH awards $3.5 million to continue development of robotic system for treating brain tumors

NIH awards $3.5 million to continue development of robotic system for treating brain tumors

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

New City of Hope CAR T cell trial focuses on HER2-positive breast cancer patients with brain metastases

New City of Hope CAR T cell trial focuses on HER2-positive breast cancer patients with brain metastases

Hippocampal avoidance during whole-brain radiotherapy reduces risk of cognitive decline

Hippocampal avoidance during whole-brain radiotherapy reduces risk of cognitive decline

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Brigatinib drug may offer first-line treatment option for ALK-positive NSCLC

Brigatinib drug may offer first-line treatment option for ALK-positive NSCLC

Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results

Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results

Immunotherapy combination shrinks melanoma that has spread to the brain

Immunotherapy combination shrinks melanoma that has spread to the brain

Immunotherapies may increase overall survival in patients with melanoma brain metastases

Immunotherapies may increase overall survival in patients with melanoma brain metastases

Clinical trial results of tucatinib with T-DM1 shows promise in treating HER2+ breast cancer

Clinical trial results of tucatinib with T-DM1 shows promise in treating HER2+ breast cancer